Sara Mary Zak

  • 2 Citations
20172019
If you made any changes in Pure, your changes will be visible here soon.

Personal profile

Training Experience

2015Residency, Cincinnati Children's Hospital Medical Center
2018Fellowship, Cincinnati Children's Hospital Medical Center

Education/Academic qualification

MD, U of Toledo

… → 2012

MS, University of Michigan

… → 2008

Fingerprint Dive into the research topics where Sara Mary Zak is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

Lymphangioleiomyomatosis Medicine & Life Sciences
Cystic Fibrosis Transmembrane Conductance Regulator Medicine & Life Sciences
Tuberous Sclerosis Medicine & Life Sciences
Mortality Medicine & Life Sciences
Pharmaceutical Preparations Medicine & Life Sciences
Cystic Fibrosis Medicine & Life Sciences
Proteins Medicine & Life Sciences
Drug Discovery Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2017 2019

  • 2 Citations
  • 1 Letter
  • 1 Review article
2 Citations (Scopus)

Lymphangioleiomyomatosis mortality in patients with tuberous sclerosis complex

Zak, S. M., Mokhallati, N., Su, W., McCormack, F. X., Franz, D. N., Mays, M., Krueger, D. A., Szczesniak, R. D. & Gupta, N., Apr 1 2019, In : Annals of the American Thoracic Society. 16, 4, p. 509-512 4 p.

Research output: Contribution to journalLetter

Lymphangioleiomyomatosis
Tuberous Sclerosis
Mortality

CFTR functional assays in drug development

Zak, S. M., Clancy, J. P. & Brewington, J. J., Nov 2 2017, In : Expert Opinion on Orphan Drugs. 5, 11, p. 889-898 10 p.

Research output: Contribution to journalReview article

Cystic Fibrosis Transmembrane Conductance Regulator
Pharmaceutical Preparations
Cystic Fibrosis
Proteins
Drug Discovery